A just-published report from the Medicines Manufacturing Industry Partnership (MMIP) – set up by the UK government and biopharma industry in 2014 to drive growth in the category – says the sector has the potential to be a driver for the UK economy in the next decade.
However, it will have to build on recent successes in areas like manufacturing of advanced therapy medicinal products (ATMP), such as cell and gene therapies and high-value medicines such as mRNA-based therapies.
